Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer: Bioidentical hormone therapy (BHRT) can be safe and effective for many people when it’s prescribed and monitored by a clinician, but safety depends on which products are used, your personal health risks, and how therapy is made/delivered. Major medical organizations advise caution about compounded “custom” BHRT and generally prefer FDA‑approved products.

What “bioidentical” means

• Bioidentical hormones are chemically identical to the hormones your body makes (most commonly 17β‑estradiol and micronized progesterone). That’s different from some synthetic hormones (progestins) or conjugated animal estrogens.

Two important categories

1. FDA‑approved bioidentical products — e.g., estradiol patches and pills (brands such as Vivelle‑Dot, Climara, Estrace), and micronized progesterone (Prometrium). These are manufactured under quality controls, have known dosages and safety data.
2. Compounded BHRT — custom‑made by compounding pharmacies. These are not FDA‑approved, can vary in dose/quality/potency, and lack large randomized trials proving benefit or safety.

What major medical organizations say

• American College of Obstetricians and Gynecologists (ACOG): Compounded bioidentical hormones are not proven to be safer or more effective than FDA‑approved products; saliva testing for dose adjustment is unreliable.
• Endocrine Society: Supports use of bioidentical hormones when FDA‑approved formulations are used; warns about unregulated compounded products.
• North American Menopause Society (NAMS): Recognizes that estradiol and micronized progesterone are bioidentical and available in FDA‑approved forms; recommends individualized therapy and cautions about compounded preparations.
• U.S. Food and Drug Administration (FDA): Warns against claims that compounded BHRT is safer or superior, and emphasizes using approved products.

Benefits and risks (brief)

• Benefits: Effective at relieving menopausal symptoms (hot flashes, night sweats, vaginal dryness), preventing bone loss, improving quality of life for many people.
• Risks: All hormone therapies can raise risks of blood clots (VTE), stroke, and may affect heart disease risk and breast cancer risk depending on type, dose, duration, and whether progesterone is included. Some evidence suggests transdermal estradiol and micronized progesterone may have lower VTE and potentially more favorable breast risk profiles than oral estrogen plus synthetic progestins, but data are complex.
• Compounded BHRT risks: potential dosing errors, inconsistent potency, contamination, and absence of rigorous safety/efficacy data.

Practical guidance

• If considering BHRT, prefer FDA‑approved bioidentical products when possible (examples: Vivelle‑Dot/Climara patches, Estrace oral estradiol, Prometrium for micronized progesterone) because of consistent quality and known safety profiles.
• Avoid providers who insist on saliva testing or claim “100% natural and risk‑free.”
• If a compounded product seems necessary (rare situations), use a pharmacy with independent accreditation (PCAB accreditation, USP compliance) and get clear documentation of ingredients, batch testing, and dosing.
• Talk to a clinician experienced in menopause care (OB‑GYN, reproductive endocrinologist, or a NAMS‑certified menopause practitioner) to individualize therapy based on your age, symptoms, cardiovascular and clotting risk, breast cancer risk, and personal preferences.
• Ask about route of administration (transdermal vs oral), lowest effective dose, monitoring plan, and alternatives (non‑hormonal pharmacologic and non‑pharmacologic options).

If you want, I can:

• Help you prepare a list of questions to ask your clinician.
• Look up NAMS‑certified menopause specialists or reputable clinics near you (e.g., Mayo Clinic, Cleveland Clinic have menopause programs).
• Summarize the pros/cons of oral vs transdermal estrogen for your specific health history.

Would you like help preparing questions for your doctor or finding a local specialist?